<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910515-0066</DOCNO><DOCID>910515-0066.</DOCID><HL>   Corrections andamp; Amplifications</HL><DATE>05/15/91</DATE><SO>WALL STREET JOURNAL (J), PAGE A2</SO><LP>   AN ITEM in the Legal Beat column in Friday's papermistakenly stated that executives and employees of DrexelBurnham Lambert Group Inc. would be eligible for a &quot;successfee,&quot; after the confirmation of a reorganization plan. Infact, only six executives will be eligible for such a feewhen the company emerges from bankruptcy-court protection.   (See: &quot;Law -- Legal Beat: Former Drexel Official IsCharged With Conspiracy, Embezzlement&quot; -- WSJ May 10, 1991)</LP><TEXT>   ---   NEW YORK CITY will seek approval from the New York stateLegislature to sell short-term notes to pay off the $2.55billion of city revenue anticipation notes that mature at theend of June. The city is seeking the authority as acontingency in case the state doesn't adopt a budget soon.Money to redeem the city's maturing revenue anticipationnotes is due to come from state aid payments, which can't bemade until the state adopts a budget. In yesterday's CreditMarkets column, the authority being sought by the city wasmisstated by a city official.   (See: &quot;Credit Markets: Bond Prices Regain Part of Friday'sBig Loss On Bargain-Hunting Moves by Foreign Investors&quot; --WSJ May 14, 1991)   ---   INVESTIGATIONS of Par Pharmaceutical Inc. and its QuadPharmaceuticals Inc. unit don't involve allegations that thecompanies submitted brand-name samples for Food and DrugAdministration approval as generic drugs. Yesterday's editionincorrectly described the nature of the investigations intothe two companies.   (See: &quot;Par Pharmaceutical Posts Widened Loss For Its 2ndQuarter&quot; -- WSJ May 14, 1991)</TEXT></DOC>